Veracity Capital LLC Argenx Se Transaction History

Veracity Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$257.11 - $319.92 $191,032 - $237,700	-743 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$268.3 - $380.31 $4,829 - $6,845	-18 Reduced 2.37%	743 $205,000
Q4 2020 Jan 25, 2021	BUY	$248.13 - $308.36 $188,826 - $234,661	761 New	761 $224,000
Q2 2020 Jul 13, 2020	SELL	$127.44 - $232.72 $223,274 - $407,725	-1,752 Closed	0 $0
Q1 2020 May 07, 2020	SELL	$108.83 - $165.23 $50,279 - $76,336	-462 Reduced 20.87%	1,752 $231,000
Q4 2019 May 07, 2020	BUY	$106.59 - $164.21 $235,990 - $363,560	2,214 New	2,214 $355,000

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Veracity Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Veracity Capital LLC with notifications on news.